Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126997021 | 12699702 | 1 | I | 2012 | 20160816 | 20160830 | 20160830 | EXP | US-DEPOMED, INC.-US-2016DEP011772 | DEPOMED | 0.00 | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126997021 | 12699702 | 1 | PS | GRALISE | GABAPENTIN | 1 | Oral | 300 MG, QD, TITRATED UP TO 1200 MG | 22544 | 300 | MG | TABLET | |||||||
| 126997021 | 12699702 | 2 | SS | GRALISE | GABAPENTIN | 1 | Oral | 300 MG, UNK, TITRATED UP TO 1200 MG | 22544 | 300 | MG | TABLET | |||||||
| 126997021 | 12699702 | 3 | SS | GRALISE | GABAPENTIN | 1 | Oral | 300 MG, QD, TITRATED UP TO 1200 MG | 22544 | 300 | MG | TABLET | |||||||
| 126997021 | 12699702 | 4 | SS | GRALISE | GABAPENTIN | 1 | Oral | 300 MG, QD, TITRATED UP TO 1200 MG | 22544 | 300 | MG | TABLET | |||||||
| 126997021 | 12699702 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, TID | 0 | 600 | MG | |||||||||
| 126997021 | 12699702 | 6 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, TID | 0 | 600 | MG | |||||||||
| 126997021 | 12699702 | 7 | SS | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, TID | 0 | 600 | MG | |||||||||
| 126997021 | 12699702 | 8 | C | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, BID | 0 | 2.5 | MG | TABLET | |||||||
| 126997021 | 12699702 | 9 | C | SOTALOL. | SOTALOL | 1 | Oral | 80 MG, QD | 0 | 80 | MG | TABLET | |||||||
| 126997021 | 12699702 | 10 | C | SOTALOL. | SOTALOL | 1 | Oral | 40 MG, QD | 0 | 40 | MG | TABLET | |||||||
| 126997021 | 12699702 | 11 | C | LOSARTAN POTASSSIUM | 2 | Oral | 50 MG, QD | 0 | 50 | MG | TABLET | ||||||||
| 126997021 | 12699702 | 12 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | TABLET | |||||||
| 126997021 | 12699702 | 13 | C | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MG, TID, PRN | 0 | 50 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126997021 | 12699702 | 1 | Neck pain |
| 126997021 | 12699702 | 5 | Product used for unknown indication |
| 126997021 | 12699702 | 8 | Atrial fibrillation |
| 126997021 | 12699702 | 9 | Atrial fibrillation |
| 126997021 | 12699702 | 11 | Hypertension |
| 126997021 | 12699702 | 12 | Atrial fibrillation |
| 126997021 | 12699702 | 13 | Back pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126997021 | 12699702 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126997021 | 12699702 | Adverse event | |
| 126997021 | 12699702 | Barrett's oesophagus | |
| 126997021 | 12699702 | Bone neoplasm | |
| 126997021 | 12699702 | Dizziness | |
| 126997021 | 12699702 | Drug dose titration not performed | |
| 126997021 | 12699702 | Drug ineffective for unapproved indication | |
| 126997021 | 12699702 | Dysphagia | |
| 126997021 | 12699702 | Dyspnoea | |
| 126997021 | 12699702 | Gastrooesophageal reflux disease | |
| 126997021 | 12699702 | Grief reaction | |
| 126997021 | 12699702 | Headache | |
| 126997021 | 12699702 | Hypertension | |
| 126997021 | 12699702 | Malignant melanoma | |
| 126997021 | 12699702 | Nausea | |
| 126997021 | 12699702 | Neuralgia | |
| 126997021 | 12699702 | Oedema | |
| 126997021 | 12699702 | Product use issue | |
| 126997021 | 12699702 | Throat cancer | |
| 126997021 | 12699702 | Tonsillar neoplasm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126997021 | 12699702 | 1 | 2012 | 0 | ||
| 126997021 | 12699702 | 4 | 201505 | 0 | ||
| 126997021 | 12699702 | 8 | 2012 | 0 | ||
| 126997021 | 12699702 | 9 | 2012 | 0 | ||
| 126997021 | 12699702 | 10 | 2012 | 0 | ||
| 126997021 | 12699702 | 11 | 2011 | 0 | ||
| 126997021 | 12699702 | 12 | 2010 | 0 |